Congxin Liang

SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.

Alexander Laird, Peter Vajkoczy, Laura K. Shawver et al. · PubMed · 2000 · 497 citations

Pathology, Cancer Biology, Tumor Biology +23

Design, Synthesis, and Evaluations of Substituted 3-[(3- or 4-Carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as Inhibitors of VEGF, FGF, and PDGF Receptor Tyrosine Kinases

Li Sun, Ngoc Quang Tran, Congxin Liang et al. · Journal of Medicinal Chemistry · 1999 · 271 citations · Full text

Tyrosine Kinase, Immunology, Pharmacotherapy +16

Ab initio studies of electron transfer: pathway analysis of effective transfer integrals

Congxin Liang, Marshall D. Newton · The Journal of Physical Chemistry · 1992 · 206 citations

Engineering, Proton-coupled Electron Transfer, Altmetric Attention Score +22

The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants

Sylvie Berthou, Daniel M. Aebersold, Laura S. Schmidt et al. · Oncogene · 2004 · 178 citations

Signal Transduction, Signaling Pathway, G Protein-coupled Receptor +8

Ab initio studies of electron transfer. 2. Pathway analysis for homologous organic spacers

Congxin Liang, Marshall D. Newton · The Journal of Physical Chemistry · 1993 · 170 citations

Engineering, Proton-coupled Electron Transfer, Altmetric Attention Score +19